Anzeige
Mehr »
Login
Montag, 09.12.2024 Börsentäglich über 12.000 News von 682 internationalen Medien
Dieses Unternehmen wird das MicroStrategy von SOLANA!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0HG6G | ISIN: SE0000736415 | Ticker-Symbol: C5G
Frankfurt
09.12.24
15:58 Uhr
1,312 Euro
+0,058
+4,63 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
OREXO AB Chart 1 Jahr
5-Tage-Chart
OREXO AB 5-Tage-Chart
RealtimeGeldBriefZeit
1,2741,40421:50

Aktuelle News zur OREXO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.12.Orexo exits depression DTx alliance with GAIA-
02.12.Orexo AB: Orexo and GAIA agree to terminate the partnership for Deprexis123Uppsala, Sweden - December 2, 2024 - Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces that Orexo AB and GAIA AG have decided to terminate the partnership agreement, covering the rights for...
► Artikel lesen
25.10.Orexo initiates new study of OX640 in participants with allergic rhinitis242OX640 is an intranasal rescue medication for the treatment of severe allergic reactions (incl. anaphylaxis) with powder-based epinephrine.OX640 is based on Orexo's proprietary drug delivery...
► Artikel lesen
24.10.Orexo AB reports Q3 results1
24.10.Orexo Interim Report Q3 2024298UPPSALA, Sweden, Oct. 24, 2024 /PRNewswire/ -- Q3 2024 highlights › Total net revenues of SEK 136.5 m (156.1) › EBITDA of SEK -0.7 m (-9.5) › Net earnings of SEK -41.9...
► Artikel lesen
OREXO Aktie jetzt für 0€ handeln
04.10.Orexo's Nomination Committee for the Annual General Meeting 2025233UPPSALA, Sweden, Oct. 4, 2024 /PRNewswire/ -- The members of the Nomination Committee for the Annual General Meeting (AGM), that takes place on May 8, 2025, have been appointed and comprises...
► Artikel lesen
03.09.Orexo to participate in Pareto Securities' 15th Annual Healthcare Conference 2024263UPPSALA, Sweden, Sept. 3, 2024 /PRNewswire/ -- Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY), today announces the company will participate in Pareto Securities' 15th Annual Healthcare Conference...
► Artikel lesen
17.07.Orexo AB GAAP EPS of -SEK1.04, revenue of SEK154M1
17.07.FDA issues CRL to Orexo's NDA for opioid overdose medication1
17.07.Orexo Q2 2024 Interim Report335UPPSALA, Sweden, July 17, 2024 /PRNewswire/ -- Making progress, while the OX124 review time extended Q2 2024 highlights Total net revenues of SEK 154.0 m (157.7)EBITDA of SEK...
► Artikel lesen
16.07.Orexo shares new information on OX124, a high-dose naloxone rescue medication in development for opioid overdose334UPPSALA, Sweden, July 16, 2024 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces that the company has received a complete response letter (CRL) from the US Food...
► Artikel lesen
10.07.Orexo AB's sustainability work ranked among top 5% by EcoVadis399UPPSALA, Sweden, July 10, 2024 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) announces that it has received a Gold Sustainability Rating by EcoVadis, one of the world's most trusted...
► Artikel lesen
08.07.Orexo: invitation to presentation of the Q2 2024 Interim Report362UPPSALA, Sweden, July 8, 2024 /PRNewswire/ -- As previously communicated Orexo will announce the Interim Report for the second quarter of 2024 on July 17 at 8 am CET. The same day at 2 pm...
► Artikel lesen
10.05.Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm874UPPSALA, Sweden, May 10, 2024 /PRNewswire/ -- On March 28, 2024, Orexo AB (publ), ("Orexo" or the "Company") (STO: ORX) (OTCQX: ORXOY) successfully issued senior secured callable floating...
► Artikel lesen
08.05.Orexo Q1 2024 Interim Report390UPPSALA, Sweden, May 8, 2024 /PRNewswire/ -- Starting 2024 with a positive EBITDA Q1 2024 highlights Total net revenues of SEK 139.3 m (158.8)EBITDA of SEK 15.9 m (-41.1)Net...
► Artikel lesen
26.04.Report from Orexo AB's annual general meeting, 26 April 2024292UPPSALA, Sweden, April 26, 2024 /PRNewswire/ -- Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 26 April 2024 resolved, in accordance...
► Artikel lesen
17.04.Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US299UPPSALA, Sweden, April 17, 2024 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that the United States Patent and Trademark Office (USPTO) has granted another...
► Artikel lesen
02.04.Orexo announces that the condition for early redemption of its existing bonds has been fulfilled377UPPSALA, Sweden, April 2, 2024 /PRNewswire/ -- On March 13, 2024, Orexo AB (publ), ("Orexo" or the "Company") (STO:ORX) (OTCQX:ORXOY) announced that the Company intends to redeem early the...
► Artikel lesen
28.03.Orexo publishes the Annual and Sustainability Report for 2023374UPPSALA, Sweden, March 28, 2024 /PRNewswire/ -- Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report...
► Artikel lesen
22.03.Orexo AB: Notice of Annual General Meeting of Orexo364UPPSALA, Sweden, March 22, 2024 /PRNewswire/ -- The shareholders in Orexo AB (publ), reg. no. 556500-0600, registered office Uppsala, are summoned to the annual general meeting, to be held...
► Artikel lesen
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1